Enter Note Done
Go to previous page in this tab
Event
  • Scientific Session
  • Bookmark Icon
  • Micro- and Nanoplastics in the Brain: From Exposure to Neural Function
  • Schedule
    Notes
  • Room 303‚ Convention Center
    Set Timezone


Chair: Emma Kasteel, Universiteit Utrecht, Netherlands
Co-Chair: Anika Dzierlenga, NIEHS

Primary Endorser: Neurotoxicology Specialty Section


Plastic pollution, and the resultant prevalence of micro- and nanoplastics (MNPs) in the environment, has been an ecological concern for decades. In recent years, emerging evidence suggests that human exposure to microplastics leads to accumulation in organ systems, and may be associated with adverse health outcomes. Exposure to MNPs occurs through ingestion, inhalation, and dermal contact, with distribution influenced by particle size, shape, and composition. Defining the contribution of MNP exposure to human disease remains a major challenge driving global investment in MNP toxicology and public health research. As more data emerges, we can ask more granular questions relevant to specific systems, outcomes, and translational implications. For example, although recent evidence indicates that MNPs may cross the blood-brain barrier (BBB) and may even accumulate in the brain at higher rates than other tissues, significant gaps remain in understanding the neurotoxic potential of MNPs. It is unclear how particle characteristics, including size, composition and aging, affect BBB translocation, cellular interactions and functional outcomes in the brain. In addition, limited data exist on how susceptibility varies across life stages, especially during development, or how systemic responses to MNP exposure may influence neural function. Studies in multiple animal models, including rodent models and several aquatic models suggest that MNPs can induce significant neurotoxicity, through the perturbation of various signaling pathways, including oxidative stress, neuroinflammation, and neurotransmission. This session specifically centers on mechanisms of neurotoxicity and brain vulnerability using integrated, human-relevant and systems-level approaches. Advances in MNP characterization and neurotoxicology models provide new opportunities to address these questions using mechanistically informed and human-relevant approaches. This session will examine approaches addressing crucial questions surrounding the toxicokinetics and toxicodynamics of microplastic particles in the brain across biological scales, from particle properties and barrier function to developmental exposure and systemic metabolic effects. The first speaker will discuss the impact of different classes of MNPs, including virgin and aged particles, on BBB integrity using human induced pluripotent stem cell (iPSC)-derived brain microvascular endothelial cells and on neuronal function using primary cells. The second speaker will focus on environmentally-derived MNPs, highlighting how real-world particle aging alters physicochemical properties and modulates interactions with neural systems. A third speaker leverages human cortical organoids to model fetal brain exposure, and will present nanoparticle disruption of neuronal tissue during development. The fourth speaker will present evidence that MNPs are a risk factor for accelerated brain aging through gut-directed metabolic reprogramming. Together, these presentations provide an integrated perspective on MNP neurotoxicity, linking particle characteristics, brain entry, developmental vulnerability, and systemic influences on neural function. This session will offer new mechanistic insight into how MNP exposure affects the brain, demonstrate how emerging analytical and human-relevant models can address pertinent toxicological questions, and inform ongoing efforts by academic, industrial and regulatory scientists to evaluate the human health risks of MNP exposure.

Session and Activity Type
Presentations